The proteasome immunosubunits, PA28 and ER-aminopeptidase 1 protect melanoma cells from efficient MART-126-35-specific T-cell recognition
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The proteasome immunosubunits, PA28 and ER-aminopeptidase 1 protect melanoma cells from efficient MART-126-35-specific T-cell recognition
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 45, Issue 12, Pages 3257-3268
Publisher
Wiley
Online
2015-09-24
DOI
10.1002/eji.201445243
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exploiting the curative potential of adoptive T-cell therapy for cancer
- (2013) Christian S. Hinrichs et al. IMMUNOLOGICAL REVIEWS
- Melanoma immunotherapy using mature DCs expressing the constitutive proteasome
- (2013) Jens Dannull et al. JOURNAL OF CLINICAL INVESTIGATION
- Induction of Protective Antitumor Immunity through Attenuation of ERAAP Function
- (2013) E. James et al. JOURNAL OF IMMUNOLOGY
- Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies
- (2013) David Sánchez-Martín et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis
- (2012) Benjamin Weide et al. JOURNAL OF CLINICAL ONCOLOGY
- The Efficiency of Human Cytomegalovirus pp65495-503 CD8+ T Cell Epitope Generation Is Determined by the Balanced Activities of Cytosolic and Endoplasmic Reticulum-Resident Peptidases
- (2012) S. Urban et al. JOURNAL OF IMMUNOLOGY
- Analysis of the Processing of Seven Human Tumor Antigens by Intermediate Proteasomes
- (2012) B. Guillaume et al. JOURNAL OF IMMUNOLOGY
- Interferon limits the effectiveness of melanoma peptide vaccines
- (2010) H.-I. Cho et al. BLOOD
- Distinct molecular mechanisms leading to deficient expression of ER-resident aminopeptidases in melanoma
- (2010) Esther Kamphausen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cutting Edge: H-2Ld Class I Molecule Protects an HIV N-Extended Epitope from In Vitro Trimming by Endoplasmic Reticulum Aminopeptidase Associated with Antigen Processing
- (2010) S. Infantes et al. JOURNAL OF IMMUNOLOGY
- Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules
- (2010) B. Guillaume et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines
- (2008) Rikke Bæk Sørensen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system
- (2008) Frédéric Ebstein et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non‐lymphoid human tissues
- (2008) Doriana Fruci et al. JOURNAL OF CELLULAR PHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started